PTC Therapeutics ( NASDAQ:PTCT – Get Free Report ) had its price target dropped by research analysts at Royal Bank of Canada from $49.00 to $26.00 in a research note issued on Monday, FlyOnTheWall reports. Royal Bank of Canada's price target suggests a potential downside of 0.99% from the stock's previous close. Other equities analysts also recently issued reports about the stock. Morgan Stanley reiterated an 'equal weight' rating and set a $47.00 price target on shares of PTC Therapeutics in a report on Friday, August 4th.

https://www.dailypolitical.com/2023/09/18/ptc-therapeutics-nasdaqptct-price-target-cut-to-26-00-by-analysts-at-royal-bank-of-canada.html

#dailypolitical